Literature DB >> 24476552

Risk factors for acute pancreatitis in patients with severe motor and intellectual disabilities.

Akiko Tamasaki1, Yoko Nishimura, Noriko Kondo, Kentaro Shirai, Yoshihiro Maegaki, Kousaku Ohno.   

Abstract

BACKGROUND: Acute pancreatitis in patients with severe motor and intellectual disability (SMID) is a rare but life-threatening condition. Possible causes of acute pancreatitis in these patients including valproic acid therapy, hypothermia and nasoduodenal tube feeding, have not yet been investigated in detail. The aim of this study was therefore to investigate the risk factors for acute pancreatitis in patients with SMID.
METHODS: Five SMID patients with acute pancreatitis and 15 SMID patients without acute pancreatitis were reviewed. Age; serum total cholesterol, triglyceride, total protein, and albumin; height; bodyweight; body surface area; body mass index; daily calorie intake; daily calorie intake per unit of body mass surface area; daily calorie intake per kilogram bodyweight; and valproic acid usage were examined.
RESULTS: A statistically significant difference was observed in serum albumin level between the two groups (P = 0.026).
CONCLUSION: The mechanism of acute pancreatitis in these patients was considered as pancreatic morphological change, acinar damage, and elevated serum trypsinogen level caused by malnutrition. It is likely that acute pancreatitis in patients with SMID occurs due to the same mechanism as in anorexia nervosa and malnourished patients. To prevent acute pancreatitis in these patients, it is important to maintain adequate nutritional status.
© 2013 The Authors. Pediatrics International © 2013 Japan Pediatric Society.

Entities:  

Keywords:  acute pancreatitis; hypoalbuminemia; malnutrition; severe motor and intellectual disabilities

Mesh:

Year:  2014        PMID: 24476552     DOI: 10.1111/ped.12231

Source DB:  PubMed          Journal:  Pediatr Int        ISSN: 1328-8067            Impact factor:   1.524


  1 in total

1.  Integrated traditional Chinese medicine improves acute pancreatitis via the downregulation of PRSS1 and SPINK1.

Authors:  Qiang Gao; Nusheng Liang
Journal:  Exp Ther Med       Date:  2015-01-20       Impact factor: 2.447

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.